Insider Transactions in Q1 2025 at Insmed Inc (INSM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
1,443
+9.94%
|
-
|
|
Feb 25
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,443
-0.48%
|
-
|
|
Feb 18
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,322
-6.72%
|
$1,465,760
$80.64 P/Share
|
|
Feb 18
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$546,400
$80.96 P/Share
|
|
Feb 18
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Feb 18
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-1.78%
|
$1,500,000
$80.9 P/Share
|
|
Feb 18
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+5.04%
|
$412,500
$22.76 P/Share
|
|
Feb 12
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,019
-3.53%
|
$401,520
$80.0 P/Share
|
|
Feb 11
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,302
-8.55%
|
$1,064,160
$80.0 P/Share
|
|
Feb 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
37,828
-9.9%
|
$2,950,584
$78.24 P/Share
|
|
Feb 10
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
42,975
-8.09%
|
$3,352,050
$78.24 P/Share
|
|
Feb 07
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10
-0.01%
|
$780
$78.91 P/Share
|
|
Feb 07
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$7,900
$79.57 P/Share
|
|
Feb 07
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
60
-0.04%
|
$4,740
$79.59 P/Share
|
|
Feb 06
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,650
-17.61%
|
$1,652,000
$80.9 P/Share
|
|
Feb 06
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,390
-15.44%
|
$2,271,200
$80.9 P/Share
|
|
Feb 06
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,910
-5.61%
|
$632,800
$80.9 P/Share
|
|
Feb 06
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
79,350
-14.88%
|
$6,348,000
$80.9 P/Share
|
|
Feb 06
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
45,605
-19.43%
|
$3,648,400
$80.9 P/Share
|
|
Feb 06
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
23,500
-16.28%
|
$1,880,000
$80.9 P/Share
|
|
Feb 06
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
33,055
-19.32%
|
$2,644,400
$80.9 P/Share
|
|
Feb 05
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,295
+28.74%
|
-
|
|
Feb 05
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,033
+26.13%
|
-
|
|
Feb 05
2025
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,373
+9.84%
|
-
|
|
Feb 05
2025
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
153,710
+22.38%
|
-
|
|
Feb 05
2025
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,680
+27.42%
|
-
|
|
Feb 05
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,295
+24.67%
|
-
|
|
Feb 05
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,943
+29.31%
|
-
|
|
Feb 03
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.72%
|
$519,080
$76.91 P/Share
|
|
Feb 03
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Feb 03
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-1.19%
|
$1,443,750
$77.0 P/Share
|
|
Feb 03
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.5%
|
$412,500
$22.76 P/Share
|
|
Jan 30
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
91,140
-48.42%
|
$7,291,200
$80.0 P/Share
|
|
Jan 30
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
91,140
+21.65%
|
$1,275,960
$14.92 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$478,100
$70.24 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
31,805
-2.62%
|
$2,226,350
$70.25 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.36%
|
$412,500
$22.76 P/Share
|
|
Jan 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
872
-0.89%
|
$59,296
$68.72 P/Share
|
|
Jan 14
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,457
-0.99%
|
$99,076
$68.72 P/Share
|
|
Jan 14
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,384
-1.36%
|
$94,112
$68.72 P/Share
|
|
Jan 10
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,902
-1.62%
|
$308,826
$63.74 P/Share
|
|
Jan 10
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,978
-0.75%
|
$187,614
$63.36 P/Share
|
|
Jan 10
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
287
-0.23%
|
$18,655
$65.4 P/Share
|
|
Jan 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
4,057
-2.0%
|
$255,591
$63.74 P/Share
|
|
Jan 10
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,066
-0.89%
|
$67,158
$63.72 P/Share
|
|
Jan 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,172
-2.89%
|
$388,836
$63.67 P/Share
|
|
Jan 10
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
319
-0.45%
|
$20,097
$63.38 P/Share
|
|
Jan 08
2025
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+4.18%
|
-
|
|
Jan 08
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,882
-1.27%
|
$124,212
$66.1 P/Share
|